Pediatric Data Not Included In Label May Be Made Public By Alternate Means
Executive Summary
FDA may seek to disseminate data collected from pediatric studies by alternate methods if enough sponsors do not include the results in labeling, the agency's June 29 "Qualifying for Pediatric Exclusivity" guidance states.